Travere Therapeutics, Inc. Ratios

Ratios Feb2009 Feb2010 Feb2011 Feb2012 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 97.98%97.81%96.59%97.67%96.63%97.01%96.91%68.18%95.96%92.12%96.68%
EBT Margin 377.87%192.95%222.80%36,086.26%74,549.02%-402.08%105.58%-43.10%-37.67%-62.02%-83.52%-95.19%-1,807.36%-302.54%-258.96%-137.45%
EBIT Margin 277.87%92.95%122.80%35,982.99%53,454.60%-282.98%-50.80%-43.58%-34.72%-48.73%-78.34%-88.83%-1,661.88%-292.17%-267.24%-138.88%
EBITDA Margin 277.87%92.95%122.80%36,086.26%74,950.37%-377.77%112.39%-35.71%-38.89%-62.83%-82.23%-86.25%-1,497.93%-256.56%-75.70%-137.31%
Operating Margin 35,982.99%53,454.60%-282.98%-50.80%-43.58%-34.72%-48.73%-78.34%-88.83%-1,661.88%-292.17%-267.24%-138.88%
Net Margin 377.87%192.95%222.80%36,086.26%74,713.02%-393.36%117.36%-35.86%-38.55%-62.51%-83.51%-85.43%310.01%48.41%182.41%-0.39%
FCF Margin 418.47%6.67%3,284.11%38,205.59%-164.92%-1.41%-3.64%4.21%-15.64%-33.31%-24.96%-677.83%-238.48%-224.48%-101.84%
Efficiency
Inventory Average 1.67M2.68M4.09M5.49M5.85M6.84M7.46M5.92M6.97M7.80M
Assets Average 0.00M77.98M323.87M518.77M522.81M614.75M656.98M606.12M692.04M724.61M730.75M691.52M
Equity Average -0.04M-0.04M-0.05M-0.06M-28.46M131.36M303.87M300.45M305.69M269.72M216.20M256.66M172.48M121.83M129.94M
Invested Capital -0.03M-0.05M-0.06M-0.06M5.37M-9.26M338.78M330.21M308.84M340.71M221.20M228.61M309.51M49.85M200.81M127.75M
Asset Utilization Ratio 0.360.310.260.300.270.270.330.020.150.200.34
Leverage & Solvency
Interest Coverage Ratio -2.78-0.93-1.23-359.83-534.55-10.73-12.30-12.16-8.16-7.30-9.22-29.04-34.25-28.91
Debt to Equity -1.27-0.750.130.070.050.070.080.020.161.16
Debt Ratio 1.220.210.080.040.030.030.030.010.010.12
Equity Ratio -15.22-16.14-0.96-0.270.590.590.560.450.370.350.390.060.250.10
Times Interest Earned -2.78-0.93-1.23-359.83-534.55-10.73-12.30-12.16-8.16-7.30-9.22-29.04-34.25-28.91
Valuation
Enterprise Value -0.00M-0.00M-0.00M40.44M122.54M299.05M467.71M458.40M527.56M830.56M547.57M1,306.65M1,734.71M1,287.88M617.39M1,301.09M
Market Capitalization 40.44M128.67M326.81M697.31M714.27M828.19M933.43M610.01M1,391.42M1,900.47M1,349.57M675.56M1,359.63M
Return Ratios
Return on Sales 3.78%1.93%2.23%360.86%747.13%-3.93%1.17%-0.36%-0.39%-0.63%-0.84%-0.85%3.10%0.48%1.82%0.00%
Return on Capital Employed 0.24%2.70%-0.21%-0.13%-0.12%-0.16%-0.24%-0.34%-0.35%-0.55%-0.70%-0.66%
Return on Invested Capital 40.13%-0.14%-0.49%-0.70%
Return on Assets -3.77%-1.42%0.36%-0.09%-0.11%-0.17%-0.22%-0.28%0.05%0.07%0.36%0.00%
Return on Equity 0.43%0.68%0.42%0.24%3.90%0.89%-0.16%-0.20%-0.34%-0.54%-0.78%0.14%0.31%2.17%-0.01%